Samalin Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
11,932
+511
+4% +$59.8K 0.48% 54
2026
Q1
$1.37M Buy
11,421
+4,373
+62% +$505K 0.49% 52
2025
Q4
$742K Buy
7,048
+78
+1% +$7.32K 0.26% 109
2025
Q3
$585K Sell
6,970
-8
-0.1% -$659 0.2% 149
2025
Q2
$552K Sell
6,978
-184
-3% -$14.6K 0.21% 155
2025
Q1
$643K Sell
7,162
-39
-0.5% -$3.64K 0.26% 115
2024
Q4
$716K Sell
7,201
-2,351
-25% -$242K 0.31% 94
2024
Q3
$1.08M Buy
9,552
+2,608
+38% +$310K 0.47% 49
2024
Q2
$860K Sell
6,944
-11
-0.2% -$1.42K 0.4% 64
2024
Q1
$918K Buy
6,955
+43
+0.6% +$5.3K 0.44% 63
2023
Q4
$754K Buy
6,912
+227
+3% +$23.6K 0.38% 76
2023
Q3
$688K Buy
6,685
+88
+1% +$9.48K 0.4% 75
2023
Q2
$761K Buy
6,597
+291
+5% +$33K 0.41% 66
2023
Q1
$671K Buy
6,306
+30
+0.5% +$3.24K 0.4% 67
2022
Q4
$696K Buy
6,276
+149
+2% +$15.2K 0.44% 65
2022
Q3
$528K Buy
6,127
+555
+10% +$49.5K 0.39% 73
2022
Q2
$508K Sell
5,572
-56
-1% -$4.96K 0.36% 79
2022
Q1
$462K Sell
5,628
-11
-0.2% -$867 0.28% 108
2021
Q4
$432K Sell
5,639
-1,579
-22% -$126K 0.26% 118
2021
Q3
$542K Buy
7,218
+242
+3% +$18.4K 0.35% 84
2021
Q2
$543K Sell
6,976
-337
-5% -$25.1K 0.35% 89
2021
Q1
$537K Sell
7,313
-474
-6% -$35K 0.36% 90
2020
Q4
$608K Buy
7,787
+553
+8% +$42.3K 0.46% 59
2020
Q3
$573K Buy
7,234
+954
+15% +$74.7K 0.51% 47
2020
Q2
$463K Sell
6,280
-2,574
-29% -$194K 0.49% 62
2020
Q1
$650K Buy
8,854
+2,942
+50% +$231K 0.87% 28
2019
Q4
$513K Buy
+5,912
New +$486K 0.43% 57

Other funds holding MRK

Samalin Investment Counsel's MRK Position: Q2 2026 in Review

Samalin Investment Counsel increased its Merck (MRK) stake by 4.5% in Q2 2026, buying an estimated $59.8K and bringing the position to 11,932 shares worth $1.53M. The position accounts for 0.48% of the portfolio, ranked #54.

Samalin Investment Counsel first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Samalin Investment Counsel held 11,932 shares of Merck worth $1.53M as of Q2 2026.
  • Samalin Investment Counsel bought 511 Merck shares in Q2 2026, an estimated $59.8K.
  • Merck made up 0.48% of Samalin Investment Counsel's portfolio in Q2 2026, its #54 holding.
  • Samalin Investment Counsel first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.